Eclipse's PACIFIC Trial Suggests Improved Outcomes For PTMR Patients
This article was originally published in The Gray Sheet
Executive Summary
Eclipse Surgical's PACIFIC trial evaluating percutaneous transmyocardial revascularization (PTMR) for refractory angina shows a significant increase in patients' exercise tolerance, but leaves open the question of whether or not they experience a placebo effect from the procedure.